Daniel S Fierer, MD Email Daniel Fierer
Infectious Disease
Mount Sinai Doctors
?
-
- Position
- ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
-
- Specialty
- Infectious Disease
-
- Language
- English
-
- Hospital Affiliation
- The Mount Sinai Hospital
-
- Phone
- Faculty Practice Associates 212-241-3150 212-241-3150
- Center for Advanced Medicine 212-241-7968 212-241-7968
Patient Experience Rating
4.5 Stars
Book an Appointment - Daniel S Fierer, MD
Dr. Fierer sees patients in the FPA, 5 East 98th Street, 11th floor, New York, NY 10029 for infectious diseases, specializing in HIV and/or Hepatitis C Virus infection. Most insurance are accepted. Dr. Fierer also sees patients with or at risk for HIV/AIDS in the Jack Martin Fund Clinic located in the Center for Ambulatory Medicine, 17 East 102nd Street, 3rd floor, New York, NY 10029. Insurances accepted are Medicaid, Medicare and ADAP.
Certification
American Board of Internal Medicine
Clinical Focus
- HIV And AIDS
- Hepatitis B
- Hepatitis C
Education
MD, Yale University School of Medicine
Residency, Internal Medicine
University of California, San Diego
Fellowship, Infectious Diseases
National Institutes of Health
Fellowship, Infectious Diseases
University of California Hospitals
Fellowship, Infectious Diseases
National Institutes of Health
Language
English
Dr. Fierer's research interests are focused on the study of acute Hepatitis C (HCV) infection in HIV-infected patients. Hepatitis C infection is highly prevalent in HIV-infected people, but Hepatitis C is rarely diagnosed during the acute phase (first 6 months) of infection and so little is known about the early course of Hepatitis C infection. Further, people who are already HIV-infected at the time they contract HCV infection may be at particular risk of having significant liver disease: a preliminary study in collaboration with Drs. Branch and Dieterich showed the presence of moderately advanced liver damage in HIV-infected people who have acute HCV infection. Dr. Fierer has initiated a larger study to evaluate HIV-infected patients referred by their physicians for acute HCV infection to further investigate the early effects of this infection on liver pathology, on the natural history of the disease, on the effectiveness of treatment, and of the mode of transmission.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Fierer during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Salamandra, LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.